<bill session="114" type="h" number="4978" updated="2018-11-21T21:40:15Z">
  <state datetime="2016-05-11T17:16:48-04:00">PASS_OVER:HOUSE</state>
  <status>
    <unknown datetime="2016-05-11T17:16:48-04:00"/>
  </status>
  <introduced datetime="2016-04-18"/>
  <titles>
    <title type="short" as="introduced">NAS Healthy Babies Act</title>
    <title type="short" as="introduced">Nurturing And Supporting Healthy Babies Act</title>
    <title type="short" as="reported to house">NAS Healthy Babies Act</title>
    <title type="short" as="reported to house">Nurturing And Supporting Healthy Babies Act</title>
    <title type="short" as="passed house">NAS Healthy Babies Act</title>
    <title type="short" as="passed house">Nurturing And Supporting Healthy Babies Act</title>
    <title type="official" as="introduced">To require the Government Accountability Office to submit to Congress a report on neonatal abstinence syndrome (NAS) in the United States and its treatment under Medicaid.</title>
    <title type="official" as="amended by house">To require the Government Accountability Office to submit to Congress a report on neonatal abstinence syndrome (NAS) in the United States and its treatment under Medicaid, and for other purposes.</title>
    <title type="display">NAS Healthy Babies Act</title>
  </titles>
  <sponsor bioguide_id="J000297"/>
  <cosponsors>
    <cosponsor bioguide_id="B001273" joined="2016-04-20"/>
    <cosponsor bioguide_id="B001286" joined="2016-04-18"/>
    <cosponsor bioguide_id="C001106" joined="2016-04-18"/>
    <cosponsor bioguide_id="H001053" joined="2016-04-28"/>
    <cosponsor bioguide_id="K000009" joined="2016-04-26"/>
    <cosponsor bioguide_id="K000381" joined="2016-05-10"/>
    <cosponsor bioguide_id="K000382" joined="2016-04-18"/>
    <cosponsor bioguide_id="M001197" joined="2016-04-26"/>
    <cosponsor bioguide_id="P000611" joined="2016-04-18"/>
    <cosponsor bioguide_id="R000395" joined="2016-04-19"/>
    <cosponsor bioguide_id="R000592" joined="2016-05-10"/>
    <cosponsor bioguide_id="R000577" joined="2016-04-26"/>
    <cosponsor bioguide_id="T000463" joined="2016-05-10"/>
    <cosponsor bioguide_id="W000812" joined="2016-04-18"/>
    <cosponsor bioguide_id="W000809" joined="2016-04-18"/>
  </cosponsors>
  <actions>
    <action datetime="2016-04-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-04-18" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2016-04-18">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2016-04-20">
      <text>Subcommittee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2016-04-20">
      <text>Forwarded by Subcommittee to Full Committee by Voice Vote .</text>
    </action>
    <action datetime="2016-04-25">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2016-04-26">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <action datetime="2016-04-27">
      <text>Committee Consideration and Mark-up Session Held.</text>
    </action>
    <calendar datetime="2016-04-27" state="REPORTED">
      <text>Ordered to be Reported (Amended) by Voice Vote.</text>
    </calendar>
    <action datetime="2016-05-10">
      <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 114-559.</text>
    </action>
    <calendar datetime="2016-05-10" calendar="Union" number="433">
      <text>Placed on the Union Calendar, Calendar No. 433.</text>
    </calendar>
    <action datetime="2016-05-11T16:54:31-04:00">
      <text>Mr. Guthrie moved to suspend the rules and pass the bill, as amended.</text>
    </action>
    <action datetime="2016-05-11T16:54:38-04:00">
      <text>Considered under suspension of the rules.</text>
      <reference ref="CR H2259-2263" label="consideration"/>
    </action>
    <action datetime="2016-05-11T16:54:40-04:00">
      <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 4978.</text>
    </action>
    <vote how="by voice vote" type="vote" datetime="2016-05-11T17:16:48-04:00" where="h" result="pass" state="PASS_OVER:HOUSE">
      <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote.</text>
      <reference ref="CR H2259-2260" label="text"/>
    </vote>
    <action datetime="2016-05-11T17:16:50-04:00">
      <text>Motion to reconsider laid on the table Agreed to without objection.</text>
    </action>
    <action datetime="2016-05-11T17:16:54-04:00">
      <text>The title of the measure was amended. Agreed to without objection.</text>
    </action>
    <action datetime="2016-05-12">
      <text>Received in the Senate and Read twice and referred to the Committee on Finance.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSFI" name="Senate Finance" activity="Referral"/>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Reporting, Markup, Referral"/>
  </committees>
  <relatedbills>
    <bill type="s" session="114" relation="identical" number="2872"/>
    <bill type="h" session="114" relation="unknown" number="5145"/>
    <bill type="s" session="114" relation="unknown" number="524"/>
    <bill type="h" session="114" relation="unknown" number="5189"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Child health"/>
    <term name="Congressional oversight"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Freedom of information"/>
    <term name="Government information and archives"/>
    <term name="Government studies and investigations"/>
    <term name="Health care costs and insurance"/>
    <term name="Health care coverage and access"/>
    <term name="Health information and medical records"/>
    <term name="Health programs administration and funding"/>
    <term name="Medicaid"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
    <term name="Public contracts and procurement"/>
  </subjects>
  <amendments/>
  <summary date="2016-05-11T13:35:17Z" status="Passed House amended">Nurturing and Supporting Healthy Babies Act or the NAS Healthy Babies Act

(Sec. 2) This bill requires the Government Accountability Office (GAO) to report on neonatal abstinence syndrome (NAS), which results from a newborn's exposure to addictive opiate drugs while in the mother's womb.

Specifically, the GAO shall report on:

 the prevalence of NAS, NAS treatment services for which coverage is available under state Medicaid programs, the settings and associated reimbursement methodologies for NAS treatment, the prevalence of utilization of various care settings under state Medicaid programs for NAS treatment, any federal barriers to treating infants with NAS under state Medicaid programs, and best practices for treating infants with NAS. The GAO shall also report on its recommendations for improvements that will ensure access to NAS treatment under state Medicaid programs.

(Sec. 3) The bill amends title XIX (Medicaid) of the Social Security Act to exclude abuse-deterrent formulations of prescription drugs from the requirement that manufacturers of single-source or innovator drugs pay additional rebates to state Medicaid programs.

(Sec. 4) Under current law, the Centers for Medicare &amp; Medicaid Services (CMS)&#160;must use predictive modeling and other analytic technologies to identify improper Medicaid claims. The bill prohibits a state agency from using or disclosing such technologies except for purposes of administering a state Medicaid program or Children's Health Insurance Program. A state agency shall have in effect adequate data security and control policies to ensure that access to such information is restricted to authorized persons for authorized uses.

(Sec. 5) The bill places $5 million in the Medicaid Improvement Fund to be available beginning in FY2021.</summary>
  <committee-reports>
    <report>H. Rept. 114-559</report>
  </committee-reports>
</bill>
